Widespread FUS mislocalization is a molecular hallmark of amyotrophic lateral sclerosis
Giulia E. Tyzack(The Francis Crick Institute), Rickie Patani(National Hospital for Neurology and Neurosurgery)
Cited by 191
Related Papers
Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study
|The Lancet Neurology|2012|606
Intron retention and nuclear loss of SFPQ are molecular hallmarks of ALS
|Nature Communications|2018|169
A neuroprotective astrocyte state is induced by neuronal signal EphB1 but fails in ALS models
|Nature Communications|2017|124